Walter L. Arons, M.D., F.A.C.P.; Carlos A. Camargo, M.D.; Charles L. Murray, M.D.; Gerald M. Reaven, M.D.; Richard A. Borrison, M.D.; Malcolm A. Bagshaw, M.D.; John A. Luetscher, M.D.
This content is PDF only. Please click on the PDF icon to access.
The purpose of this study was to evaluate pituitary megavoltage radiation in the treatment of Cushing's syndrome associated with adrenal hyperplasia. To date 12 such patients have been treated with a mean tissue dose of 4500 rads delivered to the pituitary area by the Stanford Linear Accelerator. Eight patients responded impressively by both clinical and laboratory measurements—seven of them within 1 to 12 months—after pituitary radiation and have remained free of evidence of hypercorticism to date. Follow-up on these patients has extended from 1 to 8 years with a mean interval since treatment of 5 years. Four patients—two with severe
Arons WL, Camargo CA, Murray CL, Reaven GM, Borrison RA, Bagshaw MA, et al. Megavoltage Radiation of the Pituitary in Cushing's Syndrome.. Ann Intern Med. ;72:790. doi: 10.7326/0003-4819-72-5-790_1
Download citation file:
Published: Ann Intern Med. 1970;72(5):790.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use